Nocion Therapeutics is a biopharmaceutical company developing novel treatments for silencing neurons. The company’s platform of unique molecular entities selectively affects inflamed nociceptors. Treatment using this approach aims to provide more durable and robust local analgesic effects while minimizing numbness or paralysis and other systemic off-target effects. The company’s mission is to safely alleviate suffering for millions of patients with conditions arising from activated sensory neurons including chronic cough, pain and itch.

F-Prime Capital

Partners Innovation Fund

Mission BioCapital

Canaan Partners

Nocion Therapeutics, Inc.

“We scrambled, got back, revived from the dead, if you will, and then worked again to bring in the right syndicate for this."

Boston-area biotech Nocion Therapeutics, Inc. has raised $62 million to bring its capsule-based inhaler toward Phase III testing, CEO Rick Batycky told Endpoints News. 

The startup is attempting to treat chronic cough, a condition that lasts at least eight weeks and has become more stigmatized as a result of the Covid-19 pandemic. 

"It can make you feel like a social outcast,” said Julie Grant, a general partner at Nocion investor Canaan Partners.

More on how Nocion plans to treat chronic cough with a different approach than GSK (by way of Bellus) and Merck: 

#cough #drugdevelopment #biotech #venturecapital 

We are thrilled to announce we have raised $62 million in Series B funding which will allow us to complete a Phase 2b study in Chronic Cough. Thank you to our new and existing investors for making this possible. 
https://lnkd.in/esqVrNTZ


Mitobridge is a biopharmaceutical company focused on developing treatments related to mitochondrial dysfunction.

Mitobridge

Neurona Therapeutics is a biotechnology company specializing in the development of cell-based therapies for neurological disorders.

Neurona Therapeutics

ImmunOs Therapeutics is a biotechnology company dedicated to developing immunotherapies for various diseases, including cancer and autoimmune disorders.

ImmunOs Therapeutics

NeRRe Therapeutics is a pharmaceutical company focused on developing novel treatments for pain and inflammation.

NeRRe Therapeutics

Plexium is a biotechnology company specializing in the development of novel therapeutics for neurological and pain-related disorders.

Plexium

Nocion Therapeutics is a biopharmaceutical company developing novel treatments for silencing neurons. The company's platform of unique molecular entities selectively affects inflamed nociceptors.

Nocion Therapeutics

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

private_financials

funding_rounds_analysis

company_structure

crunchbase_trigger

crunchbase_profile

li_profile

translate_crunchbase_fundingrounds

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general	May 4, 2024 5:43 AM	f78e3917
public peers	general	May 4, 2024 5:43 AM	c35c219f
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 4, 2024 5:43 AM	843b7359
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 4, 2024 5:43 AM	4c0cdacb
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 4, 2024 5:43 AM	ee686d38
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
company structure	company_analysis
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

COM:NOCIONTX

Nocion Therapeutics